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Johne’s disease (JD) is a chronic granulomatous enteritis of ruminants caused by
Mycobacterium avium subsp. paratuberculosis (MAP), which induces persistent diarrhea
and cachexia. JD causes huge economic losses to the dairy industry due to reduced
milk production and premature culling. Infected animals excrete MAP via feces during
the prolonged subclinical stage without exhibiting any clinical signs. Therefore, accurate
detection of subclinical stage animals is crucial for successful eradication of JD in
the herd. In the current study, we analyzed serum samples of MAP-infected and
non-infected cattle to identify potential biomarker candidates. First, we identified
12 differentially expressed serum proteins in subclinical and clinical shedder groups
compared to the healthy control group. Second, we conducted ELISA for three
selected biomarkers (alpha-2-macroglobulin (A2M), alpha-1-beta glycoprotein, and
transthyretin) and compared their diagnostic performance with that of two commercial
ELISA diagnostic kits. Serum A2M levels were significantly higher in the MAP-exposed,
subclinical shedder, subclinical non-shedder, and clinical shedder groups than in the
healthy control group, suggesting its possible use as a diagnostic biomarker for MAP
infection. Furthermore, A2M demonstrated a sensitivity of 90.4%, and a specificity of
100% while the two commercial ELISA kits demonstrated a sensitivity of 67.83 and
73.04% and a specificity of 100%, respectively. In conclusion, our results suggest that
measuring A2M by ELISA can be used as a diagnostic tool to detect MAP infection,
considerably improving the detection rate of subclinical shedders and MAP-exposed
animals that are undetectable using current diagnostic tools.
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INTRODUCTION
Johne’s disease (JD) is a chronic granulomatous enteritis
of ruminants caused by Mycobacterium avium subsp.
paratuberculosis (MAP) that causes significant economic
damage to dairy industries worldwide (1). The primary hosts
of MAP are farmed and free-range ruminants, including cattle,
lamb, goat, and deer (1). In addition, several researchers have also
isolated MAP from various non-ruminant wildlife and captive
animals such as rabbit, mice, rat, fox, raccoon, opossum, skunk,
coyote, Cuban hutia, parrot, wallaby, and baboon which suggests
the possibility of inter-species transmission (2–4). Furthermore,
with the possibility of an association between MAP and human
autoimmune diseases such as Crohn’s disease, multiple sclerosis,
type 1 diabetes, and rheumatoid arthritis, JD has become an
important public health disease (5–7).
The prominent clinical features of JD are persistent diarrhea,
progressive weight loss, decreased milk production, and
debilitation after a prolonged incubation period (1). During
disease progression, infected cattle shed MAP with their feces,
and bacterial shedding subsequently contaminates water, feed,
milk, and the surrounding environment (1, 8). Due to the waxy
mycolic acid layer, MAP endure harsh environmental conditions,
including dryness, low pH, and high or low temperatures; MAP
viability in pastures can be maintained for over 1 year and much
longer periods in water (9, 10). Ingestion of MAP-contaminated
materials is the primary route of infection. Therefore, rapid
detection and culling of subclinical fecal shedder from herd are
needed for the control of the JD (1, 8).
The diagnosis of JD is mainly divided into two categories.
The presence of MAP in clinical specimens such as feces, milk,
colostrum, and intestinal tissues can be detected by PCR and
bacterial culture (11). Bacterial culture from a fecal sample is the
gold standard for diagnosis of JD and the only available method
to detect viable MAP. However, observation of visible colonies
takes at least 4 weeks after inoculation due to a slow growth rate
(11). Furthermore, different disease progression rates, especially
in subclinical stages, induce intermittent bacterial shedding and
subsequently result in false-negative results for infected animals
(11). Detection of MAP by PCR is a fast and high-throughput
method that detects MAP-specific genes such as IS900, ISMap02,
and f 57 (12–14). Nevertheless, PCR-based detection has several
limitations (15). First, PCR inhibitors in feces may interfere
with the reaction and subsequently lead to false-negative results.
Second, non-specific amplification from the host and other
bacterial DNA can result in false-positive results (15). Third,
most subclinically infected animals typically shed bacteria
intermittently, which leads to false-negative results (15). Enzyme-
linked immunosorbent assay (ELISA) is generally easy to
conduct with a simple protocol and high-throughput method for
herd-level diagnosis (16). However, diagnosis of MAP-infected
cattle at subclinical stage is hampered by the low sensitivity
of currently developed commercial ELISA. Furthermore, co-
infection with other pathogens such as Mycobacterium bovis,
Fasciola hepatica, and non-tuberculous mycobacteria may reduce
diagnostic specificity by altering the immune response (17, 18).
Taken together, alternative diagnostic methods that can detect
subclinically infected animals are urgently needed for the control
and eradication of JD.
Biomarkers are measurable indicators that represent
physiological alterations during disease progression. A number
of studies have previously identified potential biomarkers in
MAP-infected animals (16, 19, 20). Acute phase proteins such as
haptoglobin and serum amyloid A were significantly increased in
various stages of paratuberculosis infection with different types of
lesions (20). Shaughnessy et al. identified three fecal biomarkers
(hsa-miR-658, hsa-miR-92a-3p, and hsa-miR-501-5p) that were
significantly upregulated in fecal samples of cattle with JD (19).
Several proteins, including ABCA13, FAM84A, DES, ABCA13,
MMP8, and SPARC, were abundant in serum of MAP-infected
animals with different pathological lesions compared to non-
infected animals, suggesting their potential for diagnosis of
subclinical stages of JD (16). In previous studies, efforts have
been made to identify biomarker candidates by analyzing host
transcripts in MAP-infected cells, mice and bovine models (21–
23), and also by discovering several genes that are upregulated in
cattle infected with MAP (24–26). However, mRNA and protein
expression of these genes demonstrated poor correlation (27)
and previous studies have been conducted with relatively small
sample sizes. To overcome these limitations, we analyzed the
proteomic profiles of serum samples from MAP-infected cattle
in different stages of disease progression for biomarker discovery
and evaluated the diagnostic potential of the novel biomarker
candidates in naturally MAP-infected cattle.
MATERIALS AND METHODS
Animal Subjects and Sample Collection
Cattle were selected from one farm in Chungcheongnam
province and two farms in Gangwon province of South Korea.
For proteomic analysis for the serum proteins, 28 cattle were
selected and classified into three groups according to the results
of fecal qPCR analysis and the level of serum MAP antibodies
detected by ELISA as follows: (1) Healthy control group (n
= 10): selected from a JD-free farm, negative for fecal PCR
and serum ELISA. (2) Subclinical shedder group (n = 8): fecal
PCR positive and ELISA negative. (3) Clinical shedder group
(n = 10): exhibiting typical JD clinical signs, positive for fecal
PCR and ELISA. For the evaluation of biomarker candidates,
126 cattle were selected according to ELISA results for serum
samples detected using two commercial ELISA diagnostic kits
(IDEXX Laboratories, Inc., Westbrook, ME, USA; ID Screen
Paratuberculosis Indirect, ID Vet, Montpellier, France) and
detection of MAP in fecal samples by qPCR targeting IS900
and ISMap02 (12, 28). In detail, 126 cattle were divided into
four groups as follows: (1) Healthy control group (n = 11):
selected from a JD-free farm, negative for fecal PCR and ELISA
negative for both commercial kits. (2) MAP-exposed group (n
= 20): selected from a JD-positive farm, negative for fecal PCR
and ELISA negative for both commercial kits. (3) Subclinical
shedder group (n = 27): fecal PCR positive and ELISA negative
for both commercial kits. (4) Subclinical non-shedder group (n
= 50): fecal PCR negative and ELISA positive for at least one
commercial kit. (5) Clinical shedder group (n = 18): exhibiting
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typical JD clinical signs, fecal PCR positive, and ELISA positive
for at least one commercial kit. Blood samples were collected
by caudal vein venipuncture with Vacutainer Plus Plastic Serum
Tubes (BD Biosciences, San Jose, CA, USA). Serumwas separated
by centrifugation at 2,500 g for 10min. Separated serum was
transferred to a 1.5mL tube and stored at −80◦C until use. The
animal study was reviewed and approved by the Animal Ethics
Committee of Seoul National University (SNU-200525-4).
Two-Dimensional Gel Electrophoresis
(2-DE) Analysis
For 2-DE analysis for the serum proteins, the pooled serum
samples were prepared from three groups. Calbiochem
ProteoExtractTM Removal Kits (Merck Millipore, Darmstadt,
Germany) was used for the removal of albumin and IgG
from pooled serum samples according to the manufacturer’s
instructions. 2-DE and image analysis with 2-DE samples were
conducted as previously described (29). Serum protein samples
were washed with 40 mmol/L Tris-hydrochloride (HCl) (pH
7.2) and 1 mmol/L ethylenediaminetetraacetic acid (EDTA)
and lysed using a buffer containing 9.5 mol/L urea, 4% 3-((3-
cholamidopropyl)dimethylammonium)-1-propanesulfonate
(CHAPS), and 35 mmol/L Tris-HCl (pH 7.2). The rehydration
solution containing 8 mol/L urea, 4% CHAPS, 10 mmol/L
dithiothreitol (DTT), and 0.2% carrier ampholytes (pH 3.0–10.0)
was mixed with the solubilized protein samples (30 µg) and
applied to immobilized pH gradient (IPG) strips (7 cm; Bio-Rad
Laboratories, Hercules, CA, USA) at pH 3.0–10.0 in a re-swelling
tray (Bio-Rad). Isoelectric focusing (IEF) was performed using
a Protein IEF Cell (Bio-Rad), and 3 preset programs consisting
of the first conditioning step (15min, 250 Vh), the linear voltage
ramping step (3 h, 4,000 Vh), and the maximum voltage ramping
step (up to 30,000 Vh). After IEF, the strips were equilibrated
with 0.375 mol/L Tris buffer (pH 8.8) containing 6 mol/L
urea, 2% sodium dodecyl sulfate (SDS), 20% glycerol, 2% DTT,
and 0.01% bromophenol blue. The equilibrated strips were
equilibrated again with the same buffer supplemented with
2.5% iodoacetamide. 2D SDS-PAGE was conducted overnight
with 12.5% separating polyacrylamide gel (8–10 cm) without a
stacking gel at 20mA per gel.
Image Analysis and In-gel Protein
Digestion
Visualization of resolved protein spots on the gels was carried
out by silver staining and scanned using a Fluor-S MultiImager
(Bio-Rad). PDQUEST 2D Gel Analysis Software version 6 (Bio-
Rad) was used to analyze spot intensities of each sample. After
silver staining, individual spots were excised from the 2-DE gels
and transferred into 1.5mL tubes. Then, 30 mmol/L potassium
ferricyanide and 100 mmol/L sodium thiosulfate were mixed
(1:1 ratio) and 100 µL of the mixture was added to the sample
and vortexed until the brownish color disappeared. Distilled
water was added to the samples 3x to cease the reaction. Then,
500 µL of 200 mmol/L ammonium bicarbonate was added to
cover the gel for 20min. The solution was discarded, and the
gel piece was dehydrated with 100 µL acetonitrile, followed
by drying using vacuum centrifugation. In-gel digestion was
conducted as previously described (30). Briefly, digestion buffer
with 12.5 ng/mL trypsin was added to the gel pieces containing
protein spots and incubated for 45min on ice. Next, the enzyme
solution was removed and 20 µL of buffer without enzyme
was added to maintain hydration during the enzymatic reaction
overnight at 37◦C. The gel pieces were then subjected to vigorous
vortexing for 30min. The digested solution was transferred
into a new 1.5mL tube and dried using vacuum centrifugation.
Finally, the samples were dissolved in 2 µL 0.1% trifluoroacetic
acid (TFA).
Peptide Mass Fingerprinting
For peptide mass fingerprinting, a matrix solution containing α-
cyano-4-hydroxycinamic acid (40 mg/mL) in 50% acetonitrile
and 0.1% TFA was prepared. An equal volume of matrix
solution was added to the sample solution and 2 µL was
transferred to the matrix-assisted laser desorption/ionization
time of flight (MALDI-TOF)/TOF target plate, quickly dried,
and washed with deionized water. After drying for 10min
at room temperature, the mixture solution was subjected to
MALDI-TOF-mass spectrometry (MS) and MS/MS analysis
using an ABI 4800 Plus TOF-TOF Mass Spectrometer (Applied
Biosystems, Framingham, MA, USA). The apparatus was set at
200-Hz Nd:355-nm YAG laser operation for analysis. Peaks with
signal/noise ratios >25 were selected, and the 10 most intense
ions were used for MS/MS analysis in 1 kV mode and 1,000–
1,250 consecutive laser exposures. Bos taurus proteins from the
National Center for Biotechnology Information (NCBI) protein
database (version 20140415; 2,845 sequences, 921,323 residues)
were used for analysis of all MALDI-TOF-MS spectra with a
molecular mass range of ±15% of that estimated from 2-DE,
allowing a peptide mass accuracy of 50 ppm. Protein Pilot
V.3.0 database software (with the MASCOT V.2. 3.02 database
search engine) was used for analysis of MS/MS spectral data
at a mass tolerance of 50 ppm. Individual peptide ion scores
were detected using a statistically significant threshold value
of P = 0.05. The MS proteomic data have been presented in
Supplementary Data 1.
ELISA
For quantitative detection of the three selected biomarkers
(alpha-2-macroglobulin [A2M], transthyretin [TTR], and alpha-
1-beta glycoprotein [A1BG]) in the serum of each animal,
commercially available ELISA kits were used according to
the manufacturer’s instructions (MyBioSource, San Diego, CA.
USA). The detection ranges of A2M, TTR, andA1BGwere 0.156–
10µg/mL, 312.5–5,000 ng/mL, and 2.5–50 ng/mL, respectively.
The intra and inter assay CV of ELISA kits were <8% and <10%,
respectively. A standard curve was generated to determine the
concentration of each biomarker in the serum samples.
Statistical Analysis
ANOVA with Tukey’s post-hoc test between different infection
groups was conducted using GraphPad Prism software version
7.00 (GraphPad Software, Inc., La Jolla, CA, USA). A P-value <
0.05 was considered statistically significant. Receiver operating
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characteristic (ROC) curve analysis was carried out for the
determination of the area under the curve (AUC) and optimal
cut-off values for each biomarker candidate. ROC curve analysis
was performed using MedCalc software version 19.4 (MedCalc
Software, Ostend, Belgium). The optimal cut-off values were
determined as the value showing the maximum Youden Index
(J = Se+Sp-1). The ability to differentiate between different
infection groups and the healthy control group was determined
with the following meaning. In detail, biomarkers with AUC
values ≥0.9 were considered to possess excellent discriminatory
power. AUC values ≥0.8 and <0.9 were considered to possess
good discriminatory power. AUC values ≥0.7 and <0.8 were
considered to possess fair discriminatory power. AUC values
<0.7 were considered to have poor discriminatory power (31).
RESULTS
Animal Subjects
The characteristics of the 28 animals selected for serum profiling
are summarized in Table 1A. The mean ELISA sample/positive
(S/P) ratios of the healthy control, subclinical shedder, and
clinical shedder groups were 4.16, 7.31, and 235.93, respectively.
The mean ages of the cattle between the groups were not
significantly different. The characteristics of the 126 animals
selected for evaluation of the biomarker candidates are also
summarized in Table 1B. The mean IDEXX ELISA S/P ratios
for the healthy control, MAP-exposed, subclinical shedder,
subclinical non-shedder, and clinical shedder groups were 3.73,
8.58, 5.84, 114.14, and 207.67, respectively. Similarly, the mean
IDVET ELISA S/P ratios for these groups were 2.49, 8.01, 2.69,
90.25, and 183.35, respectively. Collectively, the mean ages of the
cattle between the groups were not significantly different.
Protein Identification
In total, 12 significant regions were identified through MALDI-
TOF/MS analysis, and a meaningful protein list was prepared
(Table 2 and Figure 1). Two proteins (complement C3 and
TTR) were abundant only in the subclinical shedder group
compared to the healthy control group, while four proteins
(complement component 3d, A1BG precursor, complement
component C9 precursor, and uncharacterized protein) were
abundant only in the clinical shedder group. Furthermore, four
proteins (apolipoprotein A-IV, A2M, IgM heavy chain constant
region, and Kallikrein G) were abundant in both the subclinical
and clinical shedder groups. Identification of the hIgG1 heavy
chain constant region or bovine serum albumin suggested the
possibility of incomplete removal of immunoglobin and albumin.
A2M, A1BG, and TTR were selected for further evaluation of
diagnostic performance.
Biomarker ELISA
The serum levels of each biomarker candidate within different
infection groups based on the results of serum ELISA and fecal
PCR are shown in Figure 2. Serum A2M levels were significantly
higher in the MAP-exposed (p < 0.01), subclinical shedder (p
< 0.0001), subclinical non-shedder (p < 0.0001), and clinical
shedder (p < 0.0001) groups than in the healthy control group.
The serum A1BG level was significantly higher in the MAP-
exposed group than in the healthy control group (p < 0.05)
and significantly lower in the subclinical shedder group than in
the MAP-exposed group (p < 0.01). Additionally, the subclinical
non-shedder group demonstrated a higher serum A1BG level
than the subclinical shedder group (p < 0.01). The serum TTR
level was significantly higher in the subclinical non-shedder
group than in the healthy control group (p < 0.05), but did not
differ significantly among the other infection groups.
Diagnostic Utility of Selected Biomarkers
Compared with the commercial ELISA kits, the diagnostic
performance of candidate biomarker proteins was presented
according to groups (Table 3). All subjects in groups 1, 2 and
3 corresponding to the clinical shedder were positive in A2M-
ELISA. In particular, 25 out of 26 subjects in groups 5 and 6,
which were subclinical non-shedder and showed positive only
in one of the commercial kits, were diagnosed as positive by
A2M-ELISA. Above all, in group 7 belonging to the subclinical
shedder and group 8 belonging to the exposed group, 23 out of
27 subjects and 18 out of 20 subjects were diagnosed as positive
in the diagnosis using A2M-ELISA, respectively (Table 3). ROC
curve analysis suggested the possibility of discrimination between
the different infection groups using biomarker-based ELISA.
AUCs and their optimal cut-off values were calculated (Figure 3).
Comparing the healthy control group (n = 11) and the infected
cattle group altogether (n= 115), A2MELISA possessed excellent
discriminatory power with an AUC = 0.973 (95% confidence
interval [CI]: 0.946–1.000, p < 0.0001), a sensitivity of 90.4%,
and a specificity of 100%. Conversely, A1BG ELISA possessed
poor discriminatory power with an AUC= 0.641 (95%CI: 0.543–
0.739, p = 0.0048), a sensitivity of 50.4%, and a specificity of
100%. Similarly, TTR ELISA demonstrated poor discriminatory
ability with an AUC value of 0.512 (95% CI: 0.348–0.677, p =
0.8840), a sensitivity of 15.7%, and a specificity of 100%. The
IDEXX commercial ELISA kit demonstrated fair discriminatory
ability with an AUC value of 0.796 (95% CI: 0.720–0.872, p
< 0.0001), a sensitivity of 67.83%, and a specificity of 100%.
In addition, the IDVET commercial ELISA kit demonstrated
good discriminatory ability with an AUC value of 0.828 (95%
CI: 0.753–0.904, p < 0.0001), a sensitivity of 73.04%, and
a specificity of 100%. Comparison of ROC curves obtained
using the three biomarkers to those obtained using the two
commercial kits revealed that A2M demonstrated superior
diagnostic performance (Figure 3).
DISCUSSION
Detection of protein biomarkers in biological fluids can be a
promising method to diagnose and predict disease progression
in mycobacterial infections in both animal and human medicine
(32). Eradication of JD in the herd can be achieved by detecting
subclinical MAP infection, but the current diagnostic tools
require improvement. The present study revealed differences
in host protein expression within the serum of MAP-infected
cattle during different stages of JD progression, suggesting the
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TABLE 1 | Clinical characteristics of the animal subjects in this study.







Age, years, mean ± SD 2.80 ± 1.31 3.50 ± 1.51 5.42 ± 1.61
Sex, female 10 (100) 8 (100) 10 (100)
MAP isolation 0 (0) 1 (12.5) 8 (80)
Fecal PCR positive 0 (0) 8 (100) 10 (100)
Serum ELISA S/P ratio, mean ± SD IDEXX 4.06 ± 1.85 7.31 ± 4.15 235.93 ± 27.67












Age, years, mean ± SD 5.69 ± 1.6 4.33 ± 1.6 3.83 ± 2.33 4.73 ± 1.43 5 ± 1.71
Sex, female 11 (100) 20 (100) 28 (100) 50 (100) 18 (100)
MAP isolation 0 (0) 0 (0) 1 (3.6) 0 (0) 14 (77.8)
Fecal PCR positive 0 (0) 0 (0) 28 (100) 0 (0) 18 (100)
Serum ELISA S/P ratio, mean ± SD IDEXX 3.73 ± 1.82 8.58 ± 11.74 5.84 ± 7.79 114.21 ± 54.14 207.67 ± 102.30
IDVet 2.49 ± 1.24 8.01 ± 5.59 2.69 ± 2.16 90.25 ± 77.14 183.35 ± 60.99
Data are presented as numbers (percentages) unless otherwise stated.
TABLE 2 | Identification of differentially expressed serum biomarkers in MAP-infected animals.





1 Complement C3 A0A4W2D411 190190 8.36 3.20E−04 Subclinical shedder
2 Transthyretin A0A4W2BU20 15831 5.91 2.40E−04 Subclinical shedder
3 Apolipoprotein A-IV V6F7X3 42963 5.3 6.70E−24 Subclinical and clinical shedder
4 Alpha-2-macroglobulin R9QSM8 134613 5.75 1.40E−04 Subclinical and clinical shedder
5 IgM heavy chain constant region 2232299 48512 5.68 3.10E+02 Subclinical and clinical shedder
6 Complement component 3d Q693V9 34593 6.68 1.10E−20 Clinical shedder
7 alpha-1B-glycoprotein precursor Q2KJF1 54091 5.29 2.40E−05 Clinical shedder
8 Kallikrein G A0A1R3UGP4 28249 9.07 3.40E−02 Subclinical and clinical shedder
9 complement component C9 precursor A0A3Q1MU98 58618 5.66 1.10E-08 Clinical shedder
10 Uncharacterized protein A0A3Q1M3L6 41077 5.16 7.90E−04 Clinical shedder
11 hIgG1 heavy chain constant region 7547266 36510 6.09 2.70E−08 –
12 Inter-alpha-trypsin inhibitor heavy chain F1MMD7 101620 6.22 5.00E−03 –
usefulness of a host biomarker-based diagnostic approach that
provides improved sensitivity for subclinical infection.
We discovered 12 protein biomarkers for JD with the serum
samples which have different stage of infection. Among the
discovered biomarkers, three proteins (A2M, A1BG, and TTR)
were selected according to their biological significance. One of
the biologically significant protein was A2M. A2M is a large
glycoprotein that involved in trapping a broad range of proteases
for the host defense (33). A2M possesses available bait region for
diverse proteases of pathogen and snares proteases using a cage-
like structure through the structural rearrangement process with
proteolytic activation (34). Mycobacterial proteases facilitate the
invasion of host cells and promote growth during infection, and
subsequently play an important role in intracellular survival and
disease progression (35). MAP0403 is a transmembrane protein
that has 86% amino acid homology to Rv3671c, a serine protease
of M. tuberculosis (36). The transposon mutant, which has an
insertion in Rv3671c, exhibited increased susceptibility to an
acidic environment and growth defects in a mouse model (37).
Furthermore, a previous study revealed that the essentiality of
serine protease MAP0403 for maintaining the intra-bacterial pH
and response to acid stress in vitro and in vivo for intracellular
survival (36). Another serine protease, MAP3292c, significantly
enhanced intracellular survival and damage to the liver, spleen,
and lung in mice (38). Further, MAP3292c facilitated the release
of inflammatory cytokines such as IL-1β, IL-6, and TNF-α inmice
(38). Although the interaction between A2M and mycobacterial
proteases has not yet been identified, the elevated serum A2M
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FIGURE 1 | Representative two-dimensional gel electrophoresis of serum proteins from cattle according to MAP infection stages. Results from the healthy control
group (left), subclinical shedder (middle) and clinical shedder (right) groups are presented. The pH range is indicated at the top. Circled spots were cut and analyzed
by MALDI TOF MS/MS.
FIGURE 2 | Biomarker expression levels in serum samples of MAP-infected cattle showing different infection status. Serum samples of total 126 cattle were used and
grouped in to four as follows: (1) Healthy control group (HC, n = 11): selected from a JD-free farm, negative for fecal PCR and ELISA negative for both commercial
kits. (2) MAP-exposed group (E, n = 20): selected from a JD-positive farm, negative for fecal PCR and ELISA negative for both commercial kits. (3) Subclinical shedder
group (SCS, n = 27): fecal PCR positive and ELISA negative for both commercial kits. (4) Subclinical non-shedder group (SCNS, n = 50): fecal PCR negative and
ELISA positive for at least one commercial kit. (5) Clinical shedder group (CS, n = 18): fecal PCR positive, and ELISA positive for at least one commercial kit (*p <
0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001). The optimal cut-off values of A2M, A1BG, TTR, IDEXX, and IDVET ELISA are presented as red lines in each graph.
level in MAP-infected animals might be in response to the
release of MAP serine protease during infection. The interaction
between A2M and mycobacterial proteases will be elucidated in
further research.
In addition to inhibiting proteases, A2M modulates the
biological activity of cytokines and growth factors such as TNF-
α, IL-1β, IL-2, IL-6, IL-10, bFGF, β-NGF, PDGF, and TGF-β
(39). During the early stage of MAP infection, pro-inflammatory
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TABLE 3 | Comparison of diagnostic performance using candidate biomarker proteins and commercial ELISA kits.
Group* A2M A1BG TTR IDEXX ELISA IDVET ELISA
PCR IDEXX ELISA IDVET ELISA P N P N P N P N P N
1 P P P 15 0 7 8 1 14 15 0 15 0
2 P P N 2 0 1 1 0 2 2 0 0 2
3 P N P 1 0 0 1 1 0 0 1 1 0
4 N P P 21 3 17 7 1 23 24 0 24 0
5 N P N 23 1 13 11 3 21 24 0 0 24
6 N N P 2 0 1 1 2 0 0 2 2 0
7 P N N 23 4 2 25 8 19 0 27 0 27
8 N N N 18 2 16 4 2 18 0 20 0 20
9 N N N 0 11 0 11 0 11 0 11 0 11
*Groups 1, 2, and 3 belong to the clinical shedder, groups 4, 5, and 6 to the subclinical non-shedder, and group 7 to the subclinical shedder. In addition, group 8 is occupied to the
exposed group, and group 9 to the healthy control group. P, positive; N, negative.
FIGURE 3 | Receiver operating characteristic (ROC) curves of selected
biomarkers and two commercial ELISAs (IDEXX and IDVET). A2M,
alpha-2-macroglobulin; A1BG, alpha-1-beta glycoprotein; TTR, transthyretin.
The area under the ROC of A2M, A1BG, TTR, IDEXX, and IDVET ELISAs is
0.973, 0.641, 0.512, 0.796, and 0.828, respectively. The optimal cut-off values
of A2M, A1BG, TTR, IDEXX, and IDVET ELISA are 27.56, 11.93, 190.13, 8.92,
and 4.37, respectively.
cytokines such as IFN-γ, IL-12, TNF-α and IL-6 are significantly
increased in MAP-infected animals compared to healthy control
which indicating Th1 dominant immune response (40). On
the contrary, immunologic shift arises from Th1 to Th2 with
the progression of the disease suggesting the modulation of
host immune response by pathogen. Therefore, upregulation of
A2M in MAP-infected animals might be related to modulation
of the immune response during disease progression. Elevated
plasma A2M levels in tuberculous lymphadenitis, pulmonary
tuberculosis, and latent tuberculosis patients compared to
healthy controls suggested a positive correlation between higher
A2M levels and progression of mycobacterial infection (41).
Similarly, A2M was also significantly increased in the serum
of malnourished patients with active tuberculosis, suggesting
a role for A2M in mycobacterial pathogenesis (42). A2M is
mainly synthesized in liver and its production is affected by
various cytokines such as TNF-α, IL-1 and IL-6 (42). In that
regard, up-regulation of A2M can be induced by highly abundant
pro-inflammatory cytokines in MAP-infected animal. In our
study, A2M levels were significantly higher in MAP-infected
animals which including exposed and subclinical cases. Taken
together, we propose that A2M may serve as a promising
biomarker for differentiation between MAP-infected and non-
infected animals.
Other biologically significant proteins were A1BG and
TTR. A1BG is a plasma glycoprotein which belongs
to immunoglobulin supergene family that containing
immunoglobulin like domains (43). TTR is a tetrameric plasma
protein which involved in the transport of thyroid hormones
and retinol (44). A1BG was significantly elevated only in exposed
group compared to healthy control group. Also, elevated serum
TTR level was detected in subclinical non-shedder group.
However, there are no consistent changes between non-infected
and infected cattle suggesting the low diagnostic value of A1BG
and TTR in JD. These findings are contrary to previous research
which have suggested that up-regulation of serum A1BG in
experimentally MAP-infected cattle at 12 months post-infection
(PI) compared to M. bovis-infected cattle (45). Furthermore,
serum A1BG level was also up-regulated in MAP-infected cattle
at 3 months PI while decreased in non-infected cattle at same
time point (45). In addition, abundance of TTR in serum was
increased in experimentally MAP-infected cattle at 3 months PI
compared to non-infected cattle and elevated serum TTR level
was consistent up to 10 months PI compared to non-infected
cattle (45). Differences of A1BG and TTR expression in our study
may be elucidated by the origin of sample. In detail, we used
serum samples from naturally infected cattle which have over
1 year of age at least while Seth et al. (45) used experimentally
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infected neonatal calves at 6 weeks of age which leading to
different immune response compared to adult cattle.
Our results indicated that A2M ELISA yielded higher AUC
value and sensitivity than the two commercial ELISA kits
for detection of subclinical MAP-infected animals. Indeed,
A2M ELISA demonstrated superior diagnostic performance for
detection of MAP-infected animals, including subclinical cases.
A2M ELISA detected 85.18% of subclinical shedder animals,
while the IDEXX and IDVET ELISA kits detected 0%. Further,
A2M ELISA detected 90% of subclinical non-shedder cases,
while the IDEXX and IDVET ELISA kits detected 96 and 52%,
respectively. Similarly, A2M ELISA detected 100% of clinical
shedder animals, while the IDEXX and IDVET ELISA kits
detected 94.44 and 88.88%, respectively. Taken together, A2M
ELISA improved the detection rate of MAP-infected animals,
especially for the subclinical shedder group.
The MAP-exposed animals were negative for fecal PCR and
both commercial ELISA kits. However, all exposed animals were
raised together with MAP-infected animals, and some exposed
animals demonstrated fecal PCR positivity at different time
points, suggesting the high possibility of MAP infection within
the exposed group. Serum A2M levels in the MAP-exposed and
subclinical shedder groups were significantly higher than those in
the healthy control group, while this was not observed for serum
levels of the other two biomarkers. Furthermore, elevated serum
A2M levels were consistent in subclinical shedder, subclinical
non-shedder, and clinical shedder groups. Therefore, increased
serum A2M levels might be related to the host immune response
against MAP infection at early stage.
The current study provides valuable information regarding
host serum biomarkers for JD at different infection stages.
However, despite rigorous effort, we were unable to collect
a significant number of truly healthy control animal samples
due to difficulty finding a JD-free farm. Furthermore, the
detailed infection status of each animal, such as histological
observations and results from cytokine assays and tissue
bacterial cultures, would provide more reliable information for
statistical analysis.
In conclusion, the urgent need for JD biomarkers to diagnose
MAP-exposed and subclinical MAP-infected cattle arises due
to the low sensitivity of current diagnostics methods such as
commercial ELISA kits and fecal PCR. The identified serum
protein A2M may improve the diagnosis of JD, especially in
subclinical cases. Furthermore, the significant change in serum
A2M levels in infected animals suggests its important role in
JD pathogenesis. The current study reveals new possibilities to
improve current JD diagnostic tools with further testing of serum
biomarkers for accurate detection of subclinical cases, which may
help eradicate JD in the herd.
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